Tollys Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Out of Business

  • Employees
  • 11

Employees

  • Latest Deal Type
  • Liquidation

Tollys General Information

Description

Operator of a biopharmaceutical company intended to cure cancer-related diseases. The company's business involves focusing on innate immunity, particularly on the biology and modulation of a certain receptor, and the development of cancer immunotherapy to treat various types of cancer, enabling cancer patients to receive good tolerance and auto-vaccination against recurrences.

Contact Information

Website
www.tollys.fr
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 60th Floor Avenue Rockefeller
  • 69008 Lyon
  • France
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 60th Floor Avenue Rockefeller
  • 69008 Lyon
  • France

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Tollys Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Bankruptcy: Liquidation 23-May-2023 Completed Bankruptcy: Liquidation
4. Later Stage VC (Series B) 01-Sep-2020 Cancelled Pre-Clinical Trials
3. Later Stage VC (Series A) 06-Jul-2020 Completed Pre-Clinical Trials
2. Early Stage VC 16-Jul-2019 $1.18M $2.05M Completed Pre-Clinical Trials
1. Early Stage VC 18-Jun-2018 $878K $878K Completed Pre-Clinical Trials
To view Tollys’s complete valuation and funding history, request access »

Tollys Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary
Ordinary
Ordinary 28,847 $1.125495 $29.26 $29.26 1x $29.26 7.64%
To view Tollys’s complete cap table history, request access »

Tollys Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biopharmaceutical company intended to cure cancer-related diseases. The company's business involves focusi
Drug Discovery
Lyon, France
11 As of 2023

Santa Monica, CA
 

Wilmington, DE
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Tollys Competitors (2)

One of Tollys’s 2 competitors is Kite Pharma, a Formerly VC-backed company based in Santa Monica, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Kite Pharma Formerly VC-backed Santa Monica, CA
Ayala Pharmaceuticals Corporation Wilmington, DE
You’re viewing 2 of 2 competitors. Get the full list »

Tollys Patents

  • 5

    Total Documents Applications and Grants

  • Total Patents Families

  • 2

    Granted

  • 2

    Pending

  • Expiring in next 12 mo

Tollys Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3788147-A1 Tlr3 ligands that activate both epithelial and myeloid cells Pending 04-May-2018
CA-3097620-A1 Tlr3 ligands that activate both epithelial and myeloid cells Pending 04-May-2018
US-20200080084-A1 Tlr3 ligands that activate both epithelial and myeloid cells Active 04-May-2018
US-11525135-B2 Tlr3 ligands that activate both epithelial and myeloid cells Active 04-May-2018
AU-2019264232-A1 Tlr3 ligands that activate both epithelial and myeloid cells Inactive 04-May-2018 A61K48/00
To view Tollys’s complete patent history, request access »

Tollys Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

Tollys FAQs

  • When was Tollys founded?

    Tollys was founded in 2015.

  • Where is Tollys headquartered?

    Tollys is headquartered in Lyon, France.

  • What is the size of Tollys?

    Tollys has 11 total employees.

  • What industry is Tollys in?

    Tollys’s primary industry is Drug Discovery.

  • Is Tollys a private or public company?

    Tollys is a Private company.

  • What is Tollys’s current revenue?

    The current revenue for Tollys is .

  • How much funding has Tollys raised over time?

    Tollys has raised $4.63M.

  • Who are Tollys’s competitors?

    Kite Pharma and Ayala Pharmaceuticals are competitors of Tollys.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »